ArticleHuman vaccines & immunotherapeutics2025
Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea.
Hyun Jin Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.